CUSIP: 75915K101
Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
51,917,067
-
Share change
-
-1,214,364
-
Total reported value
-
$34,225,221
-
Price per share
-
$0.66
-
Number of holders
-
43
-
Value change
-
-$818,958
-
Number of buys
-
11
-
Number of sells
-
20
Quarterly Holders Quick Answers
What is CUSIP 75915K101?
CUSIP 75915K101 identifies RGLS - REGULUS THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2018
-
Previous quarter:
Q1 2018
Recent filing periods for CUSIP 75915K101:
Institutional Holders of REGULUS THERAPEUTICS INC - COM (RGLS) as of Q2 2018
As of 30 Jun 2018,
REGULUS THERAPEUTICS INC - COM (RGLS) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,917,067 shares.
The largest 10 holders included
FMR LLC, BVF INC/IL, NEA Management Company, LLC, VANGUARD GROUP INC, BOXER CAPITAL, LLC, South Dakota Investment Council, ASCEND CAPITAL, LLC, Point72 Asset Management, L.P., BlackRock Inc., and Candriam Luxembourg S.C.A..
This page lists
43
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.